Mitochondrial Mechanisms in Septic Cardiomyopathy

被引:129
作者
Cecilia Cimolai, Maria [1 ,2 ]
Alvarez, Silvia [2 ]
Bode, Christoph [1 ]
Bugger, Heiko [1 ]
机构
[1] Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol, D-79106 Freiburg, Germany
[2] Univ Buenos Aires, Natl Sci & Tech Res Council UBA CONICET, Sch Pharm & Biochem, Inst Biochem & Mol Med, Buenos Aires, DF, Argentina
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2015年 / 16卷 / 08期
关键词
septic cardiomyopathy; mitochondrial dysfunction; heart; bioenergetics; NITRIC-OXIDE SYNTHASE; INDUCED MYOCARDIAL DYSFUNCTION; INDUCED CARDIAC DYSFUNCTION; UNCOUPLING PROTEINS; OXIDATIVE STRESS; CELL-DEATH; CONTRACTILE DYSFUNCTION; HEART-MITOCHONDRIA; SEPSIS; BIOGENESIS;
D O I
10.3390/ijms160817763
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sepsis is the manifestation of the immune and inflammatory response to infection that may ultimately result in multi organ failure. Despite the therapeutic strategies that have been used up to now, sepsis and septic shock remain a leading cause of death in critically ill patients. Myocardial dysfunction is a well-described complication of severe sepsis, also referred to as septic cardiomyopathy, which may progress to right and left ventricular pump failure. Many substances and mechanisms seem to be involved in myocardial dysfunction in sepsis, including toxins, cytokines, nitric oxide, complement activation, apoptosis and energy metabolic derangements. Nevertheless, the precise underlying molecular mechanisms as well as their significance in the pathogenesis of septic cardiomyopathy remain incompletely understood. A well-investigated abnormality in septic cardiomyopathy is mitochondrial dysfunction, which likely contributes to cardiac dysfunction by causing myocardial energy depletion. A number of mechanisms have been proposed to cause mitochondrial dysfunction in septic cardiomyopathy, although it remains controversially discussed whether some mechanisms impair mitochondrial function or serve to restore mitochondrial function. The purpose of this review is to discuss mitochondrial mechanisms that may causally contribute to mitochondrial dysfunction and/or may represent adaptive responses to mitochondrial dysfunction in septic cardiomyopathy.
引用
收藏
页码:17763 / 17778
页数:16
相关论文
共 50 条
[31]   Sepsis-induced Cardiomyopathy: Mechanisms and Treatments [J].
Liu, Yan-Cun ;
Yu, Mu-Ming ;
Shou, Song-Tao ;
Chai, Yan-Fen .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[32]   Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting [J].
Carbone, Federico ;
Liberale, Luca ;
Preda, Alberto ;
Schindler, Thomas Hellmut ;
Montecucco, Fabrizio .
CELLS, 2022, 11 (18)
[33]   CARDIOMYOCYTE REPROGRAMMING IN ANIMAL MODELS OF SEPTIC SHOCK [J].
Hobai, Ion A. .
SHOCK, 2023, 59 (02) :200-213
[34]   MECHANISMS IN ACUTE SEPTIC CARDIOMYOPATHY - EVIDENCE FROM ISOLATED MYOCYTES [J].
WERDAN, K ;
MULLER, U ;
REITHMANN, C ;
PFEIFER, A ;
HALLSTROM, S ;
KOIDL, B ;
SCHLAG, G .
BASIC RESEARCH IN CARDIOLOGY, 1991, 86 (05) :411-421
[35]   Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy [J].
Haileselassie, Bereketeab ;
Mukherjee, Riddhita ;
Joshi, Amit U. ;
Napier, Brooke A. ;
Massis, Liliana M. ;
Ostberg, Nicolai Patrick ;
Queliconi, Bruno B. ;
Monack, Denise ;
Bernstein, Daniel ;
Mochly-Rosen, Daria .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 130 :160-169
[36]   Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications [J].
Werdan, Karl ;
Oelke, Anja ;
Hettwer, Stefan ;
Nuding, Sebastian ;
Bubel, Sebastian ;
Hoke, Robert ;
Russ, Martin ;
Lautenschlaeger, Christine ;
Mueller-Werdan, Ursula ;
Ebelt, Henning .
CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (08) :661-668
[37]   Septic shock and septic cardiomyopathy [J].
Ebelt, H. ;
Werdan, K. .
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2012, 107 (01) :24-28
[38]   Septic shock and septic cardiomyopathy [J].
Ebelt H. ;
Werdan K. .
Der Kardiologe, 2013, 7 (4) :261-266
[39]   Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy [J].
Salami, Oluwabukunmi Modupe ;
Habimana, Olive ;
Peng, Jin-Fu ;
Yi, Guang-Hui .
CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (01) :163-180
[40]   Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function [J].
Xin-xin Zhu ;
Xia Wang ;
Shi-yu Jiao ;
Ye Liu ;
Li Shi ;
Qing Xu ;
Jing-jing Wang ;
Yun-er Chen ;
Qi Zhang ;
Yan-ting Song ;
Ming Wei ;
Bao-qi Yu ;
Jens Fielitz ;
Frank J. Gonzalez ;
Jie Du ;
Ai-juan Qu .
Acta Pharmacologica Sinica, 2023, 44 :2184-2200